#immunotherapy

A Nature Medicine review traces the rapid advance of personalized mRNA cancer vaccines from experimental concept to active clinical development, marking a turning point for cancer immunotherapy.

New real-world data shows biologic therapies dramatically reduce severe asthma exacerbations in children, with the strongest benefits seen when treatment begins earlier in life.

Researchers are pairing lab-grown insulin cells with engineered immune bodyguards that prevent rejection — potentially eliminating the need for lifelong immunosuppression.

An 'off-the-shelf' neoantigen vaccine has demonstrated safety and immunogenicity in individuals with Lynch syndrome, a hereditary condition that dramatically increases cancer risk. The results advance the prospect of preventive cancer vaccines for people with genetic predispositions.